- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Insights 72 results
Article · Source: FondsNews
March 16, 2022
The planned amendment of the ELTIF Regulation: New opportunities for infrastructure investments
Client Alert
February 8, 2022
Europe - Between The EU Clinical Trials Regulation And The UK Guideline On Clinical Trials
Article · Source: FondsNews
December 17, 2021
Blockchain technology for the fund industry - The new crypto fund units
Article · Source: FondsBuch 2022
December 7, 2021
Pre-marketing under the German Fund Business Improvement Act – Possible Exemptions
Article · Source: ESG Kompakt
October 12, 2021
Auswirkungen der OffenlegungsVO auf Bestandsfonds
Newsletter
June 1, 2021
ESG Spezial - June 2021
Article · Source: Practical Law
May 27, 2021
Artificial intelligence: the dawn of a new legal era
Article · Source: Immobilien-FondsNews
May 17, 2021
Darlehensgewährungen an Immobiliengesellschaften nach dem Fondsstandortgesetz
Client Alert
April 29, 2021
Light and shadow for real estate funds - German Parliament passes the Fund Business Improvement Act
Article · Source: The Global Legal Post
April 28, 2021
AI's wide open: EU outlines pioneering Artificial Intelligence Act
Client Alert
April 23, 2021
EU Sets Global Standard with First Ever Artificial Intelligence Act
Article · Source: Lebensmittel & Recht
April 15, 2021
Brexit – Chancen und Risiken für die europäische Lebensmittelindustrie